These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 33269683)
1. COVID-19 and Tuberculosis-Related Catastrophic Costs. Fuady A; Houweling TAJ; Richardus JH Am J Trop Med Hyg; 2020 Dec; 104(2):436-440. PubMed ID: 33269683 [TBL] [Abstract][Full Text] [Related]
2. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios. Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415 [TBL] [Abstract][Full Text] [Related]
3. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage. Fuady A; Houweling TAJ; Mansyur M; Richardus JH Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study. Rudgard WE; Evans CA; Sweeney S; Wingfield T; Lönnroth K; Barreira D; Boccia D PLoS Med; 2017 Nov; 14(11):e1002418. PubMed ID: 29112693 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China. Yang T; Chen T; Che Y; Chen Q; Bo D BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305 [TBL] [Abstract][Full Text] [Related]
6. Association of Tuberculosis With Household Catastrophic Expenditure in South India. Muniyandi M; Thomas BE; Karikalan N; Kannan T; Rajendran K; Saravanan B; Vohra V; Okorosobo T; Lönnroth K; Tripathy SP JAMA Netw Open; 2020 Feb; 3(2):e1920973. PubMed ID: 32049293 [TBL] [Abstract][Full Text] [Related]
7. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Verguet S; Riumallo-Herl C; Gomez GB; Menzies NA; Houben RMGJ; Sumner T; Lalli M; White RG; Salomon JA; Cohen T; Foster N; Chatterjee S; Sweeney S; Baena IG; Lönnroth K; Weil DE; Vassall A Lancet Glob Health; 2017 Nov; 5(11):e1123-e1132. PubMed ID: 29025634 [TBL] [Abstract][Full Text] [Related]
8. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey. Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392 [TBL] [Abstract][Full Text] [Related]
9. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status. Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777 [TBL] [Abstract][Full Text] [Related]
10. The economic effects of supporting tuberculosis-affected households in Peru. Wingfield T; Tovar MA; Huff D; Boccia D; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans CA Eur Respir J; 2016 Nov; 48(5):1396-1410. PubMed ID: 27660507 [TBL] [Abstract][Full Text] [Related]
11. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis. Getahun B; Wubie M; Dejenu G; Manyazewal T Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063 [TBL] [Abstract][Full Text] [Related]
12. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households. Kilale AM; Pantoja A; Jani B; Range N; Ngowi BJ; Makasi C; Majaha M; Manga CD; Haule S; Wilfred A; Hilary P; Mahamba V; Nkiligi E; Muhandiki W; Matechi E; Mutayoba B; Nishkiori N; Ershova J BMC Public Health; 2022 Mar; 22(1):600. PubMed ID: 35351063 [TBL] [Abstract][Full Text] [Related]
13. Factors that determine catastrophic expenditure for tuberculosis care: a patient survey in China. Zhou C; Long Q; Chen J; Xiang L; Li Q; Tang S; Huang F; Sun Q; Lucas H Infect Dis Poverty; 2016 Jan; 5():6. PubMed ID: 26806552 [TBL] [Abstract][Full Text] [Related]
14. Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines. Florentino JL; Arao RML; Garfin AMC; Gaviola DMG; Tan CR; Yadav RP; Hiatt T; Morishita F; Siroka A; Yamanaka T; Nishikiori N PLoS One; 2022; 17(2):e0264689. PubMed ID: 35226705 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2019. Fukunaga R; Glaziou P; Harris JB; Date A; Floyd K; Kasaeva T MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):427-430. PubMed ID: 33764960 [TBL] [Abstract][Full Text] [Related]
16. Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia. Morishita F; Yadav RP; Eang MT; Saint S; Nishikiori N PLoS One; 2016; 11(9):e0162796. PubMed ID: 27611908 [TBL] [Abstract][Full Text] [Related]
17. The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Ukwaja KN; Modebe O; Igwenyi C; Alobu I Int J Tuberc Lung Dis; 2012 Jun; 16(6):733-9. PubMed ID: 22410546 [TBL] [Abstract][Full Text] [Related]
18. Universal health coverage and tuberculosis care in India in the times of Covid-19: Aligning Ayushman Bharat (National Health Assurance Scheme) to improve case detection, reduce deaths and catastrophic health expenditure. Bhargava A; Bhargava M; Meher A Natl Med J India; 2020; 33(5):298-301. PubMed ID: 34213460 [TBL] [Abstract][Full Text] [Related]
19. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa. Sweeney S; Vassall A; Guinness L; Siapka M; Chimbindi N; Mudzengi D; Gomez GB Pharmacoeconomics; 2020 Jun; 38(6):619-631. PubMed ID: 32239479 [TBL] [Abstract][Full Text] [Related]